Jump Financial, LLC Compass Pathways PLC Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	N/A	42,400 New	42,400 $362,000
Q4 2022 Feb 13, 2023	SELL	$7.84 - $11.68 $59,019 - $87,927	-7,528 Reduced 19.11%	31,872 $255,000
Q3 2022 Nov 07, 2022	BUY	$10.73 - $20.07 $422,762 - $790,758	39,400 New	39,400 $423,000
Q2 2022 Aug 09, 2022	SELL	$6.76 - $14.18 $137,904 - $289,272	-20,400 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$11.13 - $23.04 $227,052 - $470,016	20,400 New	20,400 $263,000

Q3 2021 Nov 12, 2021	SELL	$29.03 - $38.62 $982,259 - $1.31 Million	-33,836 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.29 - $39.68 $1.09 Million - $1.34 Million	33,836 New	33,836 $1.29 Million

133

27.2M

108K

172K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.